Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2018 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies or serves, such that the company's own coming volume is a consequence of those parties' trajectories? Let's analyze the transcript. Management discusses lithium supply agreements with major cathode and battery producers. They talk about secured volumes for 2021 and 2025, and negotiations. They mention that they are adjusting capital project planning accordingly. They talk about accelerating Kemerton expansion to meet hydroxide demand. They mention that customers are pushing for hydroxide due to higher nickel chemistries. They talk about long-term agreements with customers. They mention that they are building out capacity to match customer needs. But does management narrate what the counterparties are themselves doing? For example, do they describe the customers' own expansion plans, their production ramps, their adoption curves? They mention that customers are accelerating demand for battery grade lithium hydroxide. They talk about the acceleration in customers' demand. They mention that they are in negotiations for volumes. But they don't specifically describe what the customers are building or scaling. They talk about the demand from existing customers and from cathode and battery producers who are not customers today. They mention that they are confident that 2025 committed volume will increase. However, the question requires that management speaks about counterparties' business as though it were part of its own, describing their ramps, launches, rollouts, capacity additions, etc. In the transcript, management does not provide specific details about what the customers are doing. They talk about demand, but not about the customers' own trajectories. They mention that customers are pushing for hydroxide, but that's about product mix, not about the customers' expansion. Also, they mention that they have long-term supply agreements, but they don't describe the customers' plans. They talk about the fact that they are securing volumes, but that's about their own sales.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.